Head-to-head · Cost-Efficiency Index
Obu Health vs RxION Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Obu Health
Cost-first shoppers who want comparing headline monthly prices without needing pharmacy or prescriber names published up front.
Visit Obu HealthRxION Health
Cost-first shoppers who want a flat, dose-independent monthly price with no titration surcharges, outside NJ/AK/MS.
Visit RxION HealthThe verdict
Obu Health and RxION Health tie on the Cost-Efficiency Index at 57/100, so neither wins outright on the numbers. For most shoppers we'd start with Obu Health (ranked #310, a hair above #311) — Cost-first shoppers who want comparing headline monthly prices without needing pharmacy or prescriber names published up front. But RxION Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Obu Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Obu Health | RxION Health |
|---|---|---|
| Cost-Efficiency Index | 57/100 | 57/100 |
| Semaglutide / mo | $190/mo (starting dose, compounded) | $99/mo (all doses, plus a separate fee, compounded) |
| Tirzepatide / mo | $239/mo (starting dose, compounded) | $183/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $2,280 | $1,188 |
| Tirzepatide / yr (modeled) | $2,868 | $2,196 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #310 | #311 |
Obu Health
57/100Where the value is
- Real starting dollar figures published directly on the homepage without requiring intake — $190/mo semaglutide, $239/mo tirzepatide
- LegitScript certification badge displayed
- Sells adjacent longevity products (NAD+ at $219, Sermorelin starting $149/mo) on the same platform
The tradeoffs
- 'Starting' pricing means the $190/$239 figures are floors — no page found discloses whether cost rises with dose or what a maintenance dose costs
- No medical director, individually named prescriber, or compounding pharmacy is disclosed anywhere on the site
RxION Health
57/100Where the value is
- One flat monthly price regardless of dose — no per-mg price ladder to climb as you titrate up
- Free cold-pack overnight shipping and injection supplies stated as included on both drug pages
- LegitScript Certified badge displayed and independently verifiable
The tradeoffs
- The displayed $99/$183 prices sit against a struck-through $199/$299 'regular' price with no stated end date — it is unclear whether this is a permanent or temporary rate
- Not available to residents of New Jersey, Alaska, or Mississippi
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.